Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines

  • Ling Lai
  • Lin Yuan
  • Qi Cheng
  • Chunmin Dong
  • Lulu Mao
  • Steven Marc Hill
Preclinical Study


The MT1 melatonin receptor is bound and activated by the pineal hormone melatonin. This G protein-coupled melatonin receptor is expressed in human breast tumor cell lines, and when activated, mediates the growth-suppressive and steroid hormone/nuclear receptor modulatory actions of melatonin on breast tumor cells. In the current studies, we have examined the expression of the MT1 receptor in breast cancer cell lines and primary human breast tumors and correlated MT1 receptor expression with the deletion, rearrangement and amplification of the MT1 gene and established markers of breast cancer such as tumor size, stage, estrogen receptor alpha (ERα) and progesterone receptor (PR) expression. Theses studies suggest amplification of the MT1 gene in some breast tumors and an inverse correlation with ERα, PR and MT1 protein expression. Furthermore, these approaches employing immunohistochemical and immunofluorescent/confocal microscopic studies demonstrate that the MT1 receptor is localized to the caveoli and that MT1 expression in MCF-7 breast cancer cells can be repressed by estradiol and melatonin.


Melatonin MT1 receptor Human breast tumors 


  1. 1.
    Hill SM, Blask DE (1988) Effects of the pineal hormone on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 48:6121–6126PubMedGoogle Scholar
  2. 2.
    Ram PT, Dai J, Dong C, Kiefer TL, Lai L, Hill SM (2002) Involvment of the MT1 melatonin receptor in human breast cancer. Cancer Lett 179:141–150. doi:10.1016/S0304-3835(01)00873-4 CrossRefPubMedGoogle Scholar
  3. 3.
    Kiefer TL, Ram PT, Yuan L (2002) Hill: melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells. Breast Cancer Res Treat 71:37–45. doi:10.1023/A:1013301408464 CrossRefPubMedGoogle Scholar
  4. 4.
    Ross AW, Webster CA, Thompson M, Barrett P, Morgan PJ (1998) A novel interaction between inhibitory melatonin receptors and protein kinase C-dependent signal transduction in ovine pars tuberalis cells. Endocrinology 139:1723–1730. doi:10.1210/en.139.4.1723 CrossRefPubMedGoogle Scholar
  5. 5.
    Giland E, Matzkin H, Zisapel N (1997) Inactivation of melatonin receptors by protein kinase C in human prostate epithelial cells. Endocrinology 138:4255–4261. doi:10.1210/en.138.10.4255 CrossRefGoogle Scholar
  6. 6.
    Giland E, Laufer M, Matzkin H, Zisapel N (1999) Melatonin receptors in PC3 human prostate tumor cells. J Pineal Res 26:211–220. doi:10.1111/j.1600-079X.1999.tb00586.x CrossRefGoogle Scholar
  7. 7.
    Slaugenhaupt SA, Roca AL, Liebert CB, Altherr MR, Gusella JF, Reppert SM (1995) Mapping of the gene for the Mel1a-melatonin receptor to human chromosome 4 (MTNR1A) and mouse chromosome 8 (Mtnr1a). Genomics 27:355–357. doi:10.1006/geno.1995.1056 CrossRefPubMedGoogle Scholar
  8. 8.
    Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella JF (1995) Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1B melatonin receptor. Proc Natl Acad Sci USA 92:8734–8738. doi:10.1073/pnas.92.19.8734 CrossRefPubMedGoogle Scholar
  9. 9.
    Reppert SM, Weaver DR, Ebisawa T (1994) Cloning and characterization of a melatonin receptor that mediates reproductive and circadian responses. Neuron 1:1177–1185. doi:10.1016/0896-6273(94)90055-8 CrossRefGoogle Scholar
  10. 10.
    Dubocovich ML, Masana MI, Iacob S, Sauri DM (1997) Melatonin receptor antagonists that differentiate between the mel1a and mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol 355:365–375. doi:10.1007/PL00004956 CrossRefPubMedGoogle Scholar
  11. 11.
    Godson C, Reppert SM (1997) The Mel1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 138:397–404. doi:10.1210/en.138.1.397 CrossRefPubMedGoogle Scholar
  12. 12.
    Brydon L, Roka F, Petit L, de Copet P, Tissot M, Barrett P, Morgan PJ, Nanoff C, Strosberg AD, Jockers R (1999) Dual signaling of human Mel1a melatonin Receptors via Gi2, Gi3, and Gq/11 proteins. Mol Endocrinol 13:2025–2037. doi:10.1210/me.13.12.2025 CrossRefPubMedGoogle Scholar
  13. 13.
    Ram PT, Kiefer T, Silverman M, Song Y, Brown GM, Hill SM (1998) Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol Cell Endocrinol 141:53–64. doi:10.1016/S0303-7207(98)00095-1 CrossRefPubMedGoogle Scholar
  14. 14.
    Dillon D, Easley SE, Asch BB, Cheney RT, Brydon L, Jockers R, Winston JS, Brooks JS, Hurd T, Asch HL (2002) Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue. Am J Clin Pathol 118:451–458CrossRefPubMedGoogle Scholar
  15. 15.
    Yuan L, Collins AR, Dai J, Dubocovich ML, Hill SM (2002) MT1 melatonin receptor over expression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol Cell Endocrinol 192:147–156. doi:10.1016/S0303-7207(02)00029-1 CrossRefPubMedGoogle Scholar
  16. 16.
    Teplitzky SR, Kiefer TL, Cheng Q, Dwivede PD, Moroz K, Myers L, Anderson M, Collins A, Dai J, Yuan L, Spriggs LL, Blask DE, Hill SM (2001) Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid. Cancer Lett 168:155–163. doi:10.1016/S0304-3835(01)00548-1 CrossRefPubMedGoogle Scholar
  17. 17.
    Nowfar S, Teplitzky SR, Melancon K, Kiefer TL, Cheng Q, Dwived PD, Bischoff ED, Moroz K, Anderson M, Dai J, Lai L, Yuan L, Hill SM (2002) Tumor prevention by 9-cis-retinoic acid in the N-nitroso-N-methylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin. Breast Cancer Res Treat 72:33–43. doi:10.1023/A:1014912919470 CrossRefPubMedGoogle Scholar
  18. 18.
    Melaoncon K, Cheng Q, Kiefer TL, Dai J, Lai L, Dong C, Yuan L, Collins A, Thiyagarajay A, Long S, Hill SM (2005) Regression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid. Cancer Lett 227:39–48. doi:10.1016/j.canlet.2005.01.005 CrossRefGoogle Scholar
  19. 19.
    Molis T, Walters M, Hill SM (1993) Melatonin modulation of estrogen receptor expression in MCF-7 human breast cancer cells. Int J Oncol 3:687–694Google Scholar
  20. 20.
    Edidin M (2003) The state of lipid rafts: from model membranes to cells. Ann Rev Biopphys Biomol Struct 32:257–283. doi:10.1146/annurev.biophys.32.110601.142439 CrossRefGoogle Scholar
  21. 21.
    Simmons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31–39. doi:10.1038/35036052 CrossRefGoogle Scholar
  22. 22.
    Siu SWF, Lau KW, Tam PC, Shu SYW (2002) Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Prostate 52:106–122. doi:10.1002/pros.10098 CrossRefPubMedGoogle Scholar
  23. 23.
    Morcuende JA, Minhas R, Dolan L, Stevens J, Beck J, Wang K, Weinstein SL, Sheffield V (2003) Allelic variants of human melatonin 1A receptor in patients with familial adolescent idiopathic scoliosis. Spine 28:2025–2028. doi:10.1097/01.BRS.0000083235.74593.49 CrossRefPubMedGoogle Scholar
  24. 24.
    Hernandez X, Bodin L, Chesneau D, Buillaume D, Allain D, Chemineau P, Malpaux B, Migaud M (2005) Relationship between MT1 melatonin receptor gene polymorphism a seasonal physiologic responses in Ile-de-France4 ewes. Reprod Nutr Dev 45:151–162. doi:10.1051/rnd:2005012 CrossRefPubMedGoogle Scholar
  25. 25.
    Pelletier J, Bodin L, Hanocq E, Malpaux B, Teyssier J, Thimonier J, Chemineau P (2000) Association between expression of reproductive seasonality and alleles of the gene for Mel la receptor in the ewe. Biol Reprod 62:1096–1101. doi:10.1095/biolreprod62.4.1096 CrossRefPubMedGoogle Scholar
  26. 26.
    Ebisawa T, Kajimura N, Uchiyama M, Katoh M, Sekimoto M, Wantanabe T, Ozeki Y, Ikeda M, Jodi T, Sagushita M, Iwase T, Kamei Y, Kim K, Shibui K, Kodo Y, Yamada N, Toyoshima R, Okawa M, Takahashi K, Yamauchi T (1999) Allelic variants of human melatonin 1a receptor: function and prevalence in subjects with circadian rhythm sleep disorders. Biochem Biophys Res Commun 262:832–837. doi:10.1006/bbrc.1999.1308 CrossRefPubMedGoogle Scholar
  27. 27.
    Hill SM, Muraoka H, Spriggs LL, Blask DE (1992) The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett 64:249–256. doi:10.1016/0304-3835(92)90050-6 CrossRefPubMedGoogle Scholar
  28. 28.
    Mao L, Yuan L, Hill SM (2006) Inhibition of cell proliferation and blockade of cell invasion by melatonin in human breast cancer cells mediated through multiple signaling pathways. 97th Annual Mtg. American Association for Cancer Research, Abst. #495, Washington, D.C., 2006Google Scholar
  29. 29.
    Del Rio B, Garcia-Pedrero JM, Martinez-Campa C, Zuazua P, Lazo PS, Ramos S (2004) Melatonin: An endogenous specific inhibitor of estrogen receptor alpha via calmodulin. Biol Chem 279:38294–38302. doi:10.1074/jbc.M403140200 CrossRefGoogle Scholar
  30. 30.
    Gerdin MJ, Masana MI, Ren D, Miller RJ, Dubocovich ML (2003) Short-term exposure to melatonin differentially affects the functional sensitivity and trafficking of the hMT1 and hMT2 melatonin receptors. J Pharmacol Exp Ther 304:931–939. doi:10.1124/jpet.102.044990 CrossRefPubMedGoogle Scholar
  31. 31.
    Dai J, Inscho EW, Yuan L, Hill SM (2002) Modulation of intracellular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells. J Pineal Res 32:1–8. doi:10.1034/j.1600-079x.2002.1844.x CrossRefGoogle Scholar
  32. 32.
    Barrett P, Messager S, Schuster C, Moar KM, Mercer JG, Morgan PJ (2002) Pituitary adenylate cyclase-activating polypeptide acts as a paracrine regulator of melatonin-responsive cells of the ovine pars tuberalis. Endocrinology 143:2366–2375. doi:10.1210/en.143.6.2366 CrossRefPubMedGoogle Scholar
  33. 33.
    Guerrero HY, Gauer F, Schuster C, Pevet P, Masson-Pevet M (2000) Melatonin regulates the mRNA expression of the mt1 melatonin receptor in the rat pars tuberalis. Neuroendocrinology 71:163–169. doi:10.1159/000054533 CrossRefPubMedGoogle Scholar
  34. 34.
    Hazelrigg DG, Gonalez-Brito A, Lawson W, Hastings MH, Morgan PJ (1993) Prolonged exposure to melatonin leads to a time-dependent sensitization of anenylate cyclase and down-regulates melatonin receptors in pars tuberalis cells from ovine pituitary. Endocrinology 132:285–292. doi:10.1210/en.132.1.285 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • Ling Lai
    • 1
  • Lin Yuan
    • 1
  • Qi Cheng
    • 1
  • Chunmin Dong
    • 1
  • Lulu Mao
    • 1
  • Steven Marc Hill
    • 1
    • 2
  1. 1.Department of Structural & Cellular Biology, Tulane University Health Sciences CenterTulane University School of MedicineNew OrleansUSA
  2. 2.Tulane Cancer CenterTulane University School of MedicineNew OrleansUSA

Personalised recommendations